CING (STOCKS)
Cingulate Inc. Common Stock
$5.300000
+0.560000 (+11.81%)
Prev close: $4.740000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Shane J. Schaffer
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $68.83M
- Employees
- 13
- P/E (TTM)
- -1.20
- P/B (TTM)
- 2.99
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
7
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.95 | $-0.46 | -0.4944 | -108.52% |
|
Dec 2025 (Q4)
|
$-0.93 | $-0.64 | -0.2874 | -44.59% |
|
Sep 2025 (Q3)
|
$-1.35 | $-0.83 | -0.5238 | -63.40% |
|
Jun 2025 (Q2)
|
$-1.09 | $-0.89 | -0.1958 | -21.90% |
Financial Statements
| Revenues | -$1.79M |
| Benefits Costs and Expenses | $26.17M |
| Costs And Expenses | $26.17M |
| Operating Expenses | $22.36M |
| Research and Development | $9.74M |
| Other Operating Expenses | $12.63M |
| Operating Income/Loss | -$24.16M |
| Income/Loss From Continuing Operations After Tax | -$27.91M |
| Income/Loss From Continuing Operations Before Tax | -$27.71M |
| Interest Income/Expense After Provision For Losses | -$1.79M |
| Interest Income/Expense Operating, Net | -$1.79M |
| Net Income/Loss | -$27.91M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$27.91M |
| Net Income/Loss Available To Common Stockholders, Basic | -$27.92M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $12.72K |
| Preferred Stock Dividends And Other Adjustments | $12.72K |
| Provision For Loan, Lease, And Other Losses | $0.00 |
| Basic Earnings Per Share | -$4.23 |
| Diluted Earnings Per Share | -$4.23 |
| Basic Average Shares | 20,158,062 |
| Diluted Average Shares | 20,158,062 |
| Assets | $30.86M |
| Current Assets | $27.91M |
| Noncurrent Assets | $2.95M |
| Fixed Assets | $1.67M |
| Other Non-current Assets | $1.28M |
| Liabilities | $12.00M |
| Current Liabilities | $10.96M |
| Accounts Payable | $2.67M |
| Other Current Liabilities | $8.29M |
| Noncurrent Liabilities | $1.04M |
| Equity | $18.86M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $18.86M |
| Liabilities And Equity | $30.86M |
| Net Cash Flow From Operating Activities | -$19.55M |
| Net Cash Flow From Operating Activities, Continuing | -$19.55M |
| Net Cash Flow From Investing Activities | -$17.86M |
| Net Cash Flow From Investing Activities, Continuing | -$17.86M |
| Net Cash Flow From Financing Activities | $36.15M |
| Net Cash Flow From Financing Activities, Continuing | $36.15M |
| Net Cash Flow | -$1.26M |
| Net Cash Flow, Continuing | -$1.26M |
| Comprehensive Income/Loss | -$27.91M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$27.91M |
| Other Comprehensive Income/Loss | $0.00 |